Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Trigo

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Review of Neurobiology|April 9, 2016
Screening Medications for the Treatment of Cannabis Use DisorderL V Panlilio, Z Justinova, J M Trigo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 24, 2014
Thyroid cancer: SEOM clinical guidelinesJ M Trigo, J Capdevila, E Grande, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 7, 2013
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013C Camps, E Felip, R García-Campelo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)E Felip, P Garrido, J M Trigo, et al.
Science (New York, N.Y.)|November 11, 2006
Rubidium-rich asymptotic giant branch starsD A García-Hernández, P García-Lario, B Plez, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Endocrine|December 25, 2017
Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practiceM Molina-Vega, J García-Alemán, A Sebastián-Ochoa, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplantsM Hidalgo, J Hornedo, C Lumbreras, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2019
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensusD Isla, J de Castro, R García-Campelo, et al.
British Journal of Cancer|May 5, 2011
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I partJ B Vermorken, J Guigay, R Mesia, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Review of Neurobiology|April 9, 2016
Screening Medications for the Treatment of Cannabis Use DisorderL V Panlilio, Z Justinova, J M Trigo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 24, 2014
Thyroid cancer: SEOM clinical guidelinesJ M Trigo, J Capdevila, E Grande, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 7, 2013
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013C Camps, E Felip, R García-Campelo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)E Felip, P Garrido, J M Trigo, et al.
Science (New York, N.Y.)|November 11, 2006
Rubidium-rich asymptotic giant branch starsD A García-Hernández, P García-Lario, B Plez, et al.
Investigational New Drugs|November 11, 1999
A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drugI R Judson, P J Beale, J M Trigo, et al.
Endocrine|December 25, 2017
Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practiceM Molina-Vega, J García-Alemán, A Sebastián-Ochoa, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplantsM Hidalgo, J Hornedo, C Lumbreras, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2019
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensusD Isla, J de Castro, R García-Campelo, et al.
British Journal of Cancer|May 5, 2011
Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I partJ B Vermorken, J Guigay, R Mesia, et al.
Pageof 3